07312318 is referenced by 89 patents and cites 8 patents.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

Title
Internalizing anti-CD74 antibodies and methods of use
Application Number
10/377122
Publication Number
7312318 (B2)
Application Date
March 3, 2003
Publication Date
December 25, 2007
Inventor
David M Goldenberg
Mendham
NJ, US
Zhengxing Qu
Warren
NJ, US
Shui on Leung
Shatin
HK
Hans J Hansen
Picayune
MS, US
Agent
Richard A Nakashima
Faegre & Benson
Assignee
Immunomedics
NJ, US
IPC
C07K 16/00
View Original Source